Skip to content

ACS Central Science

ISSN 2374-7943

5 papers in the library · 40 citations · publishing 2017-2025

Papers

Sort Most recent Most cited

Natural Product Synthesis in the 21st Century: Beyond the Mountain Top

ACS Central Science February 14, 2024 Ryan A Shenvi 37 citations

Research into natural products emerged from humanity's curiosity about the nature of matter and its role in the materia medica of diverse civilizations. Plants and fungi, in particular, supplied materials that altered behavior, perception, and well-being profoundly. Many active principles remain well-known today: strychnine, morphine, psilocybin, ephedrine. The potential to circumvent the...

A Route to Potent, Selective, and Biased Salvinorin Chemical Space.

ACS Central Science August 23, 2023 Sarah J Hill, Nathan Dao, Vuong Q. Dang et al.

The salvinorins serve as templates for next generation analgesics, antipruritics, and dissociative hallucinogens via selective and potent agonism of the kappa-opioid receptor (KOR). In contrast to most opioids, the salvinorins lack basic amines and bind with high affinity and selectivity via complex polyoxygenated scaffolds that have frustrated deep-seated modification by synthesis. Here we...

Salvaging Salvinorin: From Hallucinogen to Potential Therapeutic through Chemical Synthesis

ACS Central Science August 10, 2023 Bhawyanth Duvvuru, Myles W. Smith

Natural products have served as rich sources of therapeutics dating back to the earliest human civilizations in the form of traditional medicines and more recently as single molecule therapies for a range of diseases. Their diverse biological activities stem from their often complex structures, which can endow natural products with desirable properties relative to synthetic molecules found in...

Dynamic Strategic Bond Analysis Yields a Ten-Step Synthesis of 20-nor-Salvinorin A, a Potent κ-OR Agonist.

ACS Central Science December 27, 2017 Jeremy J Roach, Yusuke Sasano, Cullen L. Schmid et al.

Salvinorin A (SalA) is a plant metabolite that agonizes the human kappa-opioid receptor (κ-OR) with high affinity and high selectivity over mu- and delta-opioid receptors. Its therapeutic potential has stimulated extensive semisynthetic studies and total synthesis campaigns. However, structural modification of SalA has been complicated by its instability, and efficient total synthesis has been...